Deployment o the Multidisciplinary Prospective Cohort Imminent
This study, called IMMINeNT, is looking at a group of conditions known as inflammatory diseases, which include illnesses like severe asthma, lupus, and multiple sclerosis. These conditions often affect younger people and can significantly impact their quality of life. Even though there have been advances in treatment, there's a need for better understanding of why some treatments work, why some don't, and what side effects they might have. The researchers are creating a special database and a 'biobank' (a collection of samples like blood) from patients with these conditions. The main goal is to find new markers that can predict how a disease might progress or how a patient might respond to treatment. This information could lead to developing new treatments and improving the quality of life for people living with these long-term conditions.
At a glance
What is this study about?
Many long-term inflammatory conditions, like lupus, severe asthma, and multiple sclerosis, often begin when people are young. These conditions can significantly affect daily life, impacting work, social activities, and emotional well-being. While treatments have improved over time, there's still a lot we don't know about why some treatments are effective for certain people and not others, or how to reduce side effects.
This study, called IMMINeNT, is creating a special database and a 'biobank' to learn more about these conditions. A biobank is like a secure library that stores samples, such as blood, along with important health information. By bringing this information together from many patients, researchers hope to get a clearer picture of these conditions.
The main aim is to discover new 'biomarkers'. These are like hidden clues in our bodies that can help predict how a disease might behave, how severe it might become, or how a patient might respond to a particular treatment. Finding these clues could lead to developing new and more effective treatments, helping to improve the quality of life for people living with these conditions, and potentially reducing treatment side effects.
Key takeaways
- Aims to improve understanding and treatment of long-term inflammatory diseases.
- Involves collecting information and samples during routine hospital visits.
- Helps find new 'markers' that could predict disease and treatment response.
- Does not involve new treatments; focuses on research for future patients.
- Participation will help advance medical knowledge for conditions like lupus and severe asthma.
Who may be eligible?
To join this study, you must be an adult aged 18 or over and be receiving care for an inflammatory condition at a specific hospital in Lille, France. You also need to be a part of the social security system. It's important that you can understand what the study involves and are happy to give your written permission to take part.
There are certain reasons why someone wouldn't be able to join. These include if you are pregnant or breastfeeding, if you are a minor or an adult who needs someone else to make decisions for them, or if you are unable to understand the study information or give your consent. People who are currently in an emergency situation or those who are in detention also cannot participate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you 18 years old or older?
- Are you currently being treated for an inflammatory condition at the Lille University Hospital (in specific departments like dermatology or rheumatology)?
- Are you covered by the social security system?
- Can you understand the study information and give your written permission to take part?
- Are you NOT pregnant or breastfeeding?
What does participation involve?
As this study is observational, it mostly involves collecting information during your regular hospital visits for your condition. You wouldn't be given any new medications specifically for the study. You would be asked to provide some blood samples, which would be stored in a 'biobank' for future research. You would also fill out a questionnaire called the SF-12, which asks about your general health and how you're feeling. The study is designed to follow you over time, so you would continue to provide information as part of your ongoing care.
Potential risks and benefits
Locations (1)
- Hop Claude Huriez Chu LilleVerified postcodeLille, France· Recruiting
Common questions
What is an inflammatory disease?
Inflammatory diseases happen when your body's immune system mistakenly attacks its own healthy tissues, causing swelling, pain, and other symptoms. Examples include lupus, severe asthma, and multiple sclerosis.
What is a 'biobank'?
A biobank is a secure collection of biological samples, like blood, along with health information. It's used by researchers to study diseases and find new treatments.
Will I receive new treatment in this study?
No, this study is about collecting information and samples from patients receiving their usual care. You will not receive any experimental treatments as part of this research.
How long will I be in the study?
This study aims to follow patients over time, gathering information during your regular hospital visits for your condition. The total duration isn't fixed and depends on how long you continue under active care at the hospital.
Will my personal information be kept private?
Yes, all your personal information and samples will be handled with strict confidentiality and stored securely, ensuring your privacy is protected.
How to find out more
David Launay, MD,PhD
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.